Literature DB >> 16544162

Drug discovery from natural products.

Vincent P Gullo1, James McAlpine, Kin S Lam, Dwight Baker, Frank Petersen.   

Abstract

Natural product compounds are the source of numerous therapeutic agents. Recent progress to discover drugs from natural product sources has resulted in compounds that are being developed to treat cancer, resistant bacteria and viruses and immunosuppressive disorders. Many of these compounds were discovered by applying recent advances in understanding the genetics of secondary metabolism in actinomycetes, exploring the marine environment and applying new screening technologies. In many instances, the discovery of a novel natural product serves as a tool to better understand targets and pathways in the disease process. This review describes recent progress in drug discovery from natural sources including several examples of compounds that inhibit novel drug targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16544162     DOI: 10.1007/s10295-006-0107-2

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  29 in total

1.  Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora.

Authors:  Robert H Feling; Greg O Buchanan; Tracy J Mincer; Christopher A Kauffman; Paul R Jensen; William Fenical
Journal:  Angew Chem Int Ed Engl       Date:  2003-01-20       Impact factor: 15.336

Review 2.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

Review 3.  Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery.

Authors:  William E Pierceall; Lixin Zhang; Dallas E Hughes
Journal:  Methods Mol Biol       Date:  2004

Review 4.  The need for new antibiotics.

Authors:  D M Livermore
Journal:  Clin Microbiol Infect       Date:  2004-11       Impact factor: 8.067

Review 5.  The evolving role of natural products in drug discovery.

Authors:  Frank E Koehn; Guy T Carter
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 6.  Antibiotics: where did we go wrong?

Authors:  Karen M Overbye; John F Barrett
Journal:  Drug Discov Today       Date:  2005-01-01       Impact factor: 7.851

Review 7.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

8.  Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor.

Authors:  Venkat R Macherla; Scott S Mitchell; Rama Rao Manam; Katherine A Reed; Ta-Hsiang Chao; Benjamin Nicholson; Gordafaried Deyanat-Yazdi; Bao Mai; Paul R Jensen; William F Fenical; Saskia T C Neuteboom; Kin S Lam; Michael A Palladino; Barbara C M Potts
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

9.  Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp.

Authors:  Romila D Charan; Gerhard Schlingmann; Jeffrey Janso; Valerie Bernan; Xidong Feng; Guy T Carter
Journal:  J Nat Prod       Date:  2004-08       Impact factor: 4.050

10.  Capillary electrophoretic approach to screen for enzyme inhibitors in natural extracts.

Authors:  Alexei Belenky; Dallas Hughes; Alexei Korneev; Yuriy Dunayevskiy
Journal:  J Chromatogr A       Date:  2004-10-22       Impact factor: 4.759

View more
  21 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Structural and biochemical analyses of regio- and stereospecificities observed in a type II polyketide ketoreductase.

Authors:  Pouya Javidpour; Tyler Paz Korman; Gaurav Shakya; Shiou-Chuan Tsai
Journal:  Biochemistry       Date:  2011-05-04       Impact factor: 3.162

3.  Cloning and expression of the sco2127 gene from Streptomyces coelicolor M145.

Authors:  Adán Chávez; Yolanda García-Huante; Beatriz Ruiz; Elizabeth Langley; Romina Rodríguez-Sanoja; Sergio Sanchez
Journal:  J Ind Microbiol Biotechnol       Date:  2009-02-11       Impact factor: 3.346

4.  The sequence of a 1.8-mb bacterial linear plasmid reveals a rich evolutionary reservoir of secondary metabolic pathways.

Authors:  Marnix H Medema; Axel Trefzer; Andriy Kovalchuk; Marco van den Berg; Ulrike Müller; Wilbert Heijne; Liang Wu; Mohammad T Alam; Catherine M Ronning; William C Nierman; Roel A L Bovenberg; Rainer Breitling; Eriko Takano
Journal:  Genome Biol Evol       Date:  2010-07-12       Impact factor: 3.416

Review 5.  Antibiotics for emerging pathogens.

Authors:  Michael A Fischbach; Christopher T Walsh
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

6.  Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.

Authors:  Arati Sharma; Arun K Sharma; Subbarao V Madhunapantula; Dhimant Desai; Sung Jin Huh; Paul Mosca; Shantu Amin; Gavin P Robertson
Journal:  Clin Cancer Res       Date:  2009-02-10       Impact factor: 12.531

7.  Xanthine oxidase inhibitory activity of the methanolic extracts of selected Jordanian medicinal plants.

Authors:  Mohammad M Hudaib; Khaled A Tawaha; Mohammad K Mohammad; Areej M Assaf; Ala Y Issa; Feras Q Alali; Talal A Aburjai; Yasser K Bustanji
Journal:  Pharmacogn Mag       Date:  2011-10       Impact factor: 1.085

Review 8.  Bioprospecting thermophiles for cellulase production: a review.

Authors:  Somen Acharya; Anita Chaudhary
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

9.  Investigation of anodized titanium implants coated with triterpenoids extracted from black cohosh: an animal study.

Authors:  In-Phill Park; Tae-Joo Kang; Seong-Joo Heo; Jai-Young Koak; Ju-Han Kim; Joo-Hee Lee; Shin-Jae Lee; Seong-Kyun Kim
Journal:  J Adv Prosthodont       Date:  2014-02-14       Impact factor: 1.904

10.  The occurrence of bioactive micromonosporae in aquatic habitats of the Sunshine Coast in Australia.

Authors:  Glen P Eccleston; Peter R Brooks; D Ipek Kurtböke
Journal:  Mar Drugs       Date:  2008-06-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.